Subtotal Cholecystectomy for Complicated Acute Cholecystitis: a Multicenter Prospective Observational Study

Last updated: February 8, 2022
Sponsor: Methodist Health System
Overall Status: Active - Recruiting

Phase

N/A

Condition

Liver Disorders

Gall Bladder Disorders

Intra-abdominal Infections

Treatment

N/A

Clinical Study ID

NCT04181801
052.GME.2019.D
  • Ages > 18
  • All Genders

Study Summary

We believe that subtotal cholecystectomy is a safe alternative to total cholecystectomy when the complicated gallbladder is encountered, resulting in decreased or equivalent risk of bile duct injury, major vascular injury, postoperative hemorrhage, infectious complications, and mortality. Additionally, we hope to further elucidate the expected outcomes of the varying subtypes of subtotal cholecystectomy in order to determine the safest approach, assuring the lowest need for secondary intervention, recurrent biliary disease, or need for a completion cholecystectomy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients ≥ 18 years of age
  • Preoperative definitive diagnosis of acute cholecystitis (Tokyo guideline: Table 1)

Exclusion

Exclusion Criteria:

  • Pregnant patients
  • Prior history of subtotal cholecystectomy
  • Percutaneous cholecystostomy tube in place
  • Preoperative diagnosis other than acute cholecystitis
  • Symptomatic cholelithiasis
  • Gallstone pancreatitis
  • Choledocholithiasis
  • Malignant/benign tumor
  • Others

Study Design

Total Participants: 500
Study Start date:
November 08, 2019
Estimated Completion Date:
November 30, 2022

Study Description

The first reported subtotal cholecystectomy occurred in 1955. Additional case reports and studies have been carried out, further defining this terminology as a method of avoiding misidentification injuries of the biliary system or portal vasculature when critical view of safety cannot be safely achieved. Recent data supports the safety of this decision, showing equivalent morbidity rates to total cholecystectomy in a large metanalysis of 1,231 patients. Importantly, only 4 of the 30 included studies were prospective in nature, allowing definition variability and inconsistent reporting of outcomes. Additional reports showed variable data regarding effect on hospital LOS, need for secondary intervention (including endoscopic retrograde cholangiopancreatography (ERCP), percutaneous drainage bilioma, or completion cholecystectomy), infectious complications, biliary or major vascular injury, and mortality. Some studies suggest that while subtotal cholecystectomy is associated with a decreased rate of bile duct injury and a lower conversion to open operation, this comes at the cost of increasing bile leak and recurrent biliary complications. Furthermore, the relatively recent distinction between fenestrating and reconstituting subtypes of subtotal cholecystectomy remain ill-defined in many of these studies, and outcomes between the two modalities remain variable across the literature. There is an obvious need for a head-to-head, prospective comparison between these subtypes to determine the safety and efficacy of the chosen intervention. To determine the impact of these differing techniques for subtotal cholecystectomy (namely reconstituting and fenestrating subtypes) as indicated by Tokyo Criteria (Table 1), for the management of the difficult cholecystectomy on short-term and long-term patient outcomes.

Connect with a study center

  • Methodist Dallas Medical Center

    Dallas, Texas 75203
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.